Tejas Ahire: Rh Incompatibility – A Small Blood Group Difference with Big Clinical Impact
Tejas Ahire, Junior Officer in Downstream Process at Hetero Biopharma, shared a post on LinkedIn:
“Rh Incompatibility: A Small Blood Group Difference with Big Clinical Impact
Rh incompatibility occurs when an Rh-negative mother carries an Rh-positive fetus.
During pregnancy, the mother’s immune system may develop antibodies against fetal red blood cells, which can affect future Rh-positive pregnancies.
Key points:
- First pregnancy is usually unaffected
- IgG antibodies can cross the placenta
- May cause fetal anemia, jaundice, and severe complications
- Anti-D immunoglobulin is highly effective in prevention
Understanding this mechanism highlights the importance of antenatal screening and timely preventive care.
As healthcare professionals and students, knowing the science behind Rh incompatibility helps us appreciate how early intervention can save lives.
Did you know that a simple Anti-D injection can prevent most cases of Rh incompatibility?”
Stay updated with Hemostasis Today.
-
Sep 10, 2026, 11:25Andreas Glenthøj: New Sickle Cell Trait Data in UpToDate
-
Sep 10, 2026, 10:53A New Era of Hemophilia Screening and Diagnosis in Women and Girls – ISTH
-
Sep 10, 2026, 10:03Investing in Youth, Transforming Hemophilia Care – WFH
-
Sep 10, 2026, 09:51Ronke Oke BEM: 20 Years of Newborn Sickle Cell Screening in England
-
Sep 10, 2026, 09:41Seunghwan Song: Hemlibra and the Science That Changed Hemophilia A Care
-
Sep 10, 2026, 09:20Mark Dawson: A Radical Rethink of Hemophilia Treatment
-
Sep 10, 2026, 07:26Carly Newton: Every Donation Helps Save Lives
-
Sep 10, 2026, 07:152023 ACR/EULAR APS Classification Criteria – APS Foundation of America
-
Sep 10, 2026, 07:03When Platelet Function Matters More Than Platelet Count – Glanzmann’s Research Foundation